BioMarin Pharmaceutical, Inc. (BMRN)
58.98
-1.06
(-1.77%)
USD |
NASDAQ |
Dec 30, 10:43
BioMarin Pharmaceutical Shareholders Equity (Quarterly): 6.057B for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amicus Therapeutics, Inc. | 230.42M |
| Gilead Sciences, Inc. | 21.54B |
| Merck & Co., Inc. | 51.85B |
| AbbVie, Inc. | -2.642B |
| Bristol Myers Squibb Co. | 18.55B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.615B |
| Total Liabilities (Quarterly) | 1.558B |
| Debt to Equity Ratio | 0.1009 |
| Current Ratio | 4.828 |
| Net Debt Paydown Yield | 0.94% |